Journal of Neuromuscular Diseases
Published by SAGE
ISSN : 2214-3599 eISSN : 2214-3602
Abbreviation : J. Neuromuscul. Dis.
Aims & Scope
The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular genetics/correlates, pathogenesis, pharmacology, diagnosis and treatment of acquired and genetic neuromuscular diseases (including muscular dystrophy, myasthenia gravis, spinal muscular atrophy, neuropathies, myopathies, myotonias and myositis).
The journal publishes research reports, reviews, short communications, letters-to-the-editor, and will consider research that has negative findings.
The journal is dedicated to providing an open forum for original research in basic science, translational and clinical research that will improve our fundamental understanding and lead to effective treatments of neuromuscular diseases.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3.4 |
2024 | 3.20 |
Journal Rank
Year | Value |
---|---|
2024 | 4708 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 929 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.016 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 43 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature
Citation: 244
Authors: Johanna C.W., Corinne G.C., Jan J.G.M., André L.M., Baziel G.M.
-
Advances in Treatment of Spinal Muscular Atrophy – New Phenotypes, New Challenges, New Implications for Care
Citation: 182
Authors: David C., Astrid, Janbernd
-
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
Citation: 167
Authors: Jacqueline, Jacinda, Amanda, Anne, Basil, John, Richard, R. Rodney, Katherine, Nancy, Thomas, Perry B., Thomas O., Douglas, Jill
-
Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 – A Prospective Observational Study
Citation: 166
Authors: Maggie C., Stephan, Simone, Julia, Miriam, Eva, Kristina, Astrid, Hanns, Janbernd, Benedikt
-
Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials
Citation: 151
Authors: Pierre G., Benjamin, Olivier, Paulo, Pierre-Yves, Eduard, Dmitry
-
AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort
Citation: 147
Authors: Samiah A., Stephen J., Linda, Lindsay N., Richard, Kathleen R., Sukumar, Douglas M., Douglas E., Courtney, Francis, Melissa, James, W. David, John T., Brian K., Jerry R.
-
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
Citation: 143
Authors: Zaïda, Catherine L., David, Erik, Oksana, Grace, Soledad, Maria E., Kyriaki, Konstantina, Hugh, Leanne, Matthew I., Anna J., Teodora, Velina, Sophelia, Lawrence, Craig, Yi, Jen, Nina, Petr, Jaana, Maggie C., Olivia, Veronika, Marta, Agnes, Venkatarman, Farhad, Filippo, Alessandra, En, Janneke C., Miriam, Richard, Anna, Anna, Rosário, Elena, Svetlana, Vedrana Milic, Dina, Manuel, Clemens, Andrea, Jordi, Eduard, A. Ayşe, Tunca, Haluk, Rasha, Angela, Andriy V., Ann S., Holly L., Jan, Kevin M., Volker, Kate, Christophe, Jan J., Hanns
-
Increasing Role of Titin Mutations in Neuromuscular Disorders
Citation: 128
Authors: Marco, Jaakko, Anna, Bjarne, Peter